The No. 1 Rising Cancer in Women: Dr. Kemi Doll on Uterine Cancer, Fibroids, HRT & What Women Need to Know

The No. 1 Rising Cancer in Women: Dr. Kemi Doll on Uterine Cancer, Fibroids, HRT & What Women Need to Know

June 16, 2026 · 1h 4m · Episode 75

About this episode

Dr. Taz and Dr. Kemi Doll discuss the rising issue of uterine cancer in women, particularly focusing on health equity and the importance of womb health.

What happens when the womb is treated as separate from the rest of women’s health? In this episode of hol+, Dr. Taz sits down with Dr. Kemi Doll, double board-certified gynecologic oncologist, equity scientist, researcher, coach, and author of A Terrible Strength: The Hidden Crisis of the Black Womb and Your Survival Guide to Healing , for a powerful conversation about womb health, uterine cancer, fibroids, HRT, health equity, and why so many women are still being taught to normalize symptoms that deserve care. Together, they explore why womb health is not only about pregnancy, fertility, or menopause, but a lifelong part of women’s physical, emotional, hormonal, and whole-body health. Dr. Doll shares how her grandmother’s death in childbirth, her mother’s near-death experience, and her own work as a gynecologic cancer surgeon shaped her mission to bring the uterus back into the center of women’s health. Dr. Taz and Dr. Doll also discuss why uterine cancer is rising, why Black women are twice as likely to die after a uterine cancer diagnosis, and how gaps in research, screening, and diagnostic tools may leave women of color especially vulnerable. They unpack the role of…

People in this episode

Host: Dr. Taz MD

Guest: Dr. Kemi Doll

Topics covered

Keywords

Mentioned in this episode

Books & works: A Terrible Strength: The Hidden Crisis of the Black Womb and Your Survival Guide to Healing

More episodes of hol+ with Dr. Taz MD | The Future of Medicine is Holistic

Explore listener stats, chart rankings, contacts and more on the hol+ with Dr. Taz MD | The Future of Medicine is Holistic podcast page.